Company: PBR
Filing Date: 2025-07-25
Form Type: 6-K
Source: 0001292814-25-002747
Chunk: 0

Company: PETROBRAS - PETROLEO BRASILEIRO SA
Filing Date: 2025-07-25
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private
Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange
Act of 1934

For the month of July, 2025

Commission File Number 1-15106

PETRÓLEO BRASILEIRO S.A. – PETROBRAS

(Exact name of registrant
as specified in its charter)

Brazilian Petroleum Corporation – PETROBRAS

(Translation of Registrant's
name into English)

Avenida Henrique Valadares, 28 – 9th floor
20231-030 – Rio de Janeiro, RJ
Federative Republic of Brazil

(Address of principal
executive office)

Indicate by check mark
whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form
40-F _______

Indicate by check mark
whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _______ No___X____</div>

Petrobras clarifies news reported in the media—

Rio de Janeiro, July 24, 2025 –Petróleo Brasileiro S.A. – Petrobras, in relation to news reported in the media regarding a petition filed with the Administrative
Council for Economic Defense (CADE), hereby announces that it has requested to join as a third party in the merger review proceedings
evaluating the possible purchase of shares in NSP Inv., a subsidiary of Novonor S.A. (“Novonor”) which controls Braskem S.A.,
by Nelson Tanure.

According to the rules set forth in the
Braskem Shareholders' Agreement, entered into between Petrobras and Novonor, Petrobras has preemptive and tag-along rights in the event
of a direct or indirect sale of the shares held by Novonor in Braskem.

It should be clarified that Petrobras
became aware, through a press release published by Braskem on July 17, 2025, of CADE's approval of a potential transaction involving Novonor's
stake in Braskem. For this reason